Mark Cuban Cost Plus Drug Company, PBC and 9amHealth Join Forces to Expand Access to Affordable Obesity Care

Collaboration brings low-cost obesity medications plus expert-led, whole-body care to employer benefit plans.

SAN DIEGO and DALLAS, June 17, 2025 /PRNewswire/ -- 9amHealth, a leader in complete cardiometabolic care, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), today announced a collaboration that will make obesity medications more affordable and accessible to employers nationwide. 9amHealth will leverage low-cost oral medications from Cost Plus Drugs as an option to treat obesity within a clinically validated prescribing protocol. 9amHealth's curated obesity program for self-insured employers also includes branded obesity GLP-1 medications at transparent monthly costs through direct manufacturer partnerships. Together, the two companies offer a complete, cost-efficient solution to employers seeking to expand coverage for weight management and chronic co-conditions like diabetes, high cholesterol, and hypertension.

This collaboration brings together Cost Plus Drugs' groundbreaking transparent pricing model and 9amHealth's high-touch, at a time where patient demand and rising medical costs have come to a head. Employees will now have access to low-cost, high-quality medications through Cost Plus Drugs, alongside 9amHealth's expert Care Team of Obesity Medicine physicians, endocrinologists, and cardiometabolic specialists—all available without long waits or costly appointments.

"We are thrilled to collaborate with 9amHealth in our mission to make prescription drugs more affordable for consumers," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. "At Cost Plus Drugs, our commitment to transparent drug pricing has always been unwavering, and with clinical leaders in obesity like 9amHealth, we are dedicated to providing affordable and accessible healthcare solutions for patients with cardiometabolic conditions."

With the demand for weight-loss medications skyrocketing and obesity coverage becoming a key priority for employers, this new offering provides a turnkey solution: clinically guided, evidence-based care combined with affordable medication access. Employers and their pharmacy benefit managers (PBMs) can now address obesity as part of a comprehensive cardiometabolic strategy–at a fraction of traditional costs.

"Our collaboration with Mark Cuban Cost Plus Drugs gives employers a way to provide expert medical management of obesity, without the massive price tag," said Paul Geevarghese, COO and Co-Founder of 9amHealth. "We're not only lowering the cost of medications, we're also connecting members to real, human care: specialists in obesity and diabetes, clinical pharmacists, and ongoing nutritional support with registered dietitians–all from the comfort of home."

Key Benefits for Employers:

• Virtual medical care from 9amHealth's expert Care Team, including Obesity Medicine physicians and endocrinologists
• Access to first-generation medications used in the treatment of obesity at transparent, discounted prices through www.costplusdrugs.com
• Coverage for branded obesity GLP-1s at fixed monthly costs with variable cost share through 9amHealth's manufacturer programs
• At-home lab testing, prescription delivery, and 24/7 clinical support
• Scalable solution for managing obesity, diabetes, and related chronic conditions in employer populations

This collaboration arrives at a critical time, as more employers look to offer clinically effective and financially sustainable weight-loss coverage. Cost Plus Drugs and 9amHealth are answering that call together.

To learn more about how to bring this solution to your workforce, visit www.join9am.com/employers.

About 9amHealth

9amHealth offers complete cardiometabolic care—a first-of-its-kind, whole-body approach to preventing and treating obesity, diabetes, high cholesterol, and hypertension. They partner with employers, health plans, and PBMs to provide effective health benefits for those living with chronic conditions. Their members receive personalized care plans, prescription delivery, at-home lab tests, and unlimited specialist access. 9amHealth was founded in 2021 by the team behind mySugr and is backed by 7Wire Ventures, Cigna Ventures, Human Capital, Founders Fund, and Define Ventures. Learn more at www.join9am.com.

About Mark Cuban Cost Plus Drug Company, PBC

The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line. Cost Plus Drugs transparently charges a standard markup on every drug it sells. The costplusdrugs.com online pharmacy launched in January 2022 now carries over 2,300 prescription products, delivered by mail to thousands of happy customers every day. Customers can also go to participating retail pharmacies to receive Cost Plus Drugs pricing through the Team Cuban Card. Cost Plus Drugs is working with health plans, managed-care organizations, PBMs, and self-insured employers to bring these same savings to benefit plans nationwide. Learn more at www.markcubancostplusdrugcompany.com.

SOURCE 9amHealth